Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
Aldeyra Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 22, 2019
Aldeyra Therapeutics reported fiscal year 2018 executive compensation information on April 22, 2019.
In 2018, four executives at Aldeyra Therapeutics received on average a compensation package of $1.6M, a 3% increase compared to previous year.
Average pay of disclosed executives at Aldeyra Therapeutics
Todd C. Brady, Chief Executive Officer, received $2.9M in total, which increased by 21% compared to 2017. 45% of Brady's compensation, or $1.3M, was in option awards. Brady also received $253K in non-equity incentive plan, $506K in salary, as well as $827K in stock awards.
David McMullin, Chief Commercial Officer, received a compensation package of $1.6M. 81% of the compensation package, or $1.3M, was in option awards.
David J. Clark, Chief Medical Officer, earned $1.2M in 2018, a 9% increase compared to previous year.
Stephen J. Tulipano, Chief Financial Officer, received $884K in 2018, which decreases by 31% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 22, 2019.